The California Division of Workers’ Compensation’s Pharmacy and Therapeutics Committee is meeting virtually from 12:30-2:30 p.m. April 19.
Members of the committee that advises the DWC on evidence-based changes to its prescription drug formulary will continue deliberations on coverage for items including artificial tears, topical analgesics and topical lidocaine, and review drug listings in the Medical Treatment Utilization Schedule.
Members will also hear an update on issues relating to COVID-19.
Meeting materials and an agenda with instructions for participating are here.
...
Comments